Document is current
Any future updates will be listed below
-
Authors
Di Salvo, Ivana
Mnzava, Dorcas
Nicoletti, Giovanni Jacopo
Senkoro, Elizabeth
Ndege, Robert C.
Huang, Dorothy J.
Makunja, Nathalia Tobias
Kassiga, George I.
Kaufmann, Andreas M.
Weisser, Maja
Kind, André B.
-
Funding
Funding for this research was provided by:
University Hospital of Basel
Abviris Deutschland GmbH
Swiss Cancer Research Foundation (BIL KFS-4986-02-2020)
Freiwillige Akademische Gesellschaft
University of Basel
- License Information
-
More Information
Article History
Received: 28 August 2022
Accepted: 26 January 2023
First Online: 10 March 2023
Declarations
:
: This protocol was approved by the Institutional Review Board of the Ifakara Health Institute IHI-IRB (IHI/IRB/No: 43–2020), National Institute for Medical Research in Tanzania (NIMR/HQ/R.8a/ Vol. IX/3611) and the Tanzania Medicines and Medical Devices Authority (TMDA-WEB0021/CTR/002/03) in Tanzania; and Ethikkommission Nordwest- und Zentralschweiz (AO_2021_00006) in Switzerland.Informed consent from study participants is written.
: Not applicable.
: All authors declare that they have no competing interests. AKa declares he is inventor of QG-MPH and will receive royalties if the assay will be commercially implemented, which at this point is not the case.
